Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions demonstrate a general consensus supporting the article's findings, with users referencing recent literature and clinical experiences. For example, one user notes that 'many procedural interventions can be conducted while patients are on isotretinoin,' indicating agreement, while another comments on the limited evidence regarding PDT and LLLT, showing engagement with specific treatments. The tone varies from supportive to cautious, reflecting ongoing debates about clinical implications.
Most discussions align with the article's conclusion that recent evidence does not strongly support delaying procedures after isotretinoin.
Posts show high interest by referencing specific procedures and studies, indicating active engagement.
Comments often include detailed opinions or interpretations of the literature, reflecting moderate engagement.
The discussions suggest that the article could influence clinical decisions or spark debates about treatment timing, but the impact appears preliminary.
@JiaJia_5555 Many procedural interventions can be conducted while patients are on isotretinoin. However, PDT and particularly LLLT have very limited evidence to suggest they are helpful, so I think low value to combining with isotretinoin for most patients. https://t.co/72K2lipM3O
@lacpe12 There is minimal data to support a risk of isotretinoin and abnormal scarring/wound healing. For cutaneous procedures, the consensus is that procedures can be considered during or shortly after isotretinoin (except fully ablative laser or dermabrasion). https://t.co/72K2liHnso
Discontinuing retinoids and isotretinoin before procedures is often based on outdated beliefs. Recent studies show no significant risk of abnormal scarring or delayed healing from nonablative treatments, supporting more…
This video discusses the use of isotretinoin in dermatology, covering its pharmacology, mechanism of action, and clinical applications including acne, dermatitis, rosacea, and skin cancers. It also reviews recent…
✍記録2017 JAMA Derm（PMID: 28658462）によるシステマティックレビューでは、イソトレチノイン服用中または直後でも、非アブレーティブレーザー（医療脱毛含む）施術に関する明確な禁止根拠はないと結論。一律「半年空ける」ルールは見直し対象。 https://t.co/O35i8ksJKG
@JiaJia_5555 Many procedural interventions can be conducted while patients are on isotretinoin. However, PDT and particularly LLLT have very limited evidence to suggest they are helpful, so I think low value to combining with isotretinoin for most patients. https://t.co/72K2lipM3O
@lacpe12 There is minimal data to support a risk of isotretinoin and abnormal scarring/wound healing. For cutaneous procedures, the consensus is that procedures can be considered during or shortly after isotretinoin (except fully ablative laser or dermabrasion). https://t.co/72K2liHnso
JM
ポ肌